Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$3.76 - $6.02 $37,600 - $60,199
10,000 New
10,000 $47,000
Q4 2022

Feb 08, 2023

BUY
$8.86 - $25.04 $12.4 Million - $35.1 Million
1,403,578 New
1,403,578 $0

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $1.13B
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Herr Investment Group LLC Portfolio

Follow Herr Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Herr Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Herr Investment Group LLC with notifications on news.